Literature DB >> 14533026

Methotrexate in inflammatory eye disease.

Richard Stawell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14533026     DOI： 10.1076/ocii.11.2.79.15918

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN： 0927-3948            Impact factor:   3.070


× No keyword cloud information.
  3 in total

1.  A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.

Authors:  Roma Chilengi; Rashid Juma; Ahmed M Abdallah; Mahfudh Bashraheil; Hudson Lodenyo; Priscilla Nyakundi; Evelyn Anabwani; Amina Salim; Gabriel Mwambingu; Ednah Wenwa; Julie Jemutai; Chemtai Kipkeu; George O Oyoo; Simon N Muchohi; Gilbert Kokwaro; Tim Niehues; Trudie Lang; Alexis Nzila
Journal:  Malar J       Date:  2011-03-16       Impact factor: 2.979

2.  Challenges with cataract surgery in pars planitis patients.

Authors:  Andrzej Grzybowski; Piotr Kanclerz; Uwe Pleyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-07       Impact factor: 3.117

3.  Anticancer agents against malaria: time to revisit?

Authors:  Alexis Nzila; John Okombo; Ruy Perez Becker; Roma Chilengi; Trudie Lang; Tim Niehues
Journal:  Trends Parasitol       Date:  2010-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.